rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    AMGN
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Biotechnology Market Companies 2027 Analysis: Amgen, Gilead, Regeneron, Vertex and Moderna Post Strong 2026 Results as Billion-Dollar Deals Reshape a Market Headed for USD 6.34 Trillion by 2035
      Nov 17Yahoo FinanceAMGNGILDMRNAREGN
      Dow Jones Biotech Giant Amgen In Buy Zone Amid Ongoing Stock Market Weakness

      Dow Jones biotech giant Amgen stock is trading in a buy zone following its recent breakout move amid the ongoing market weakness.

      Nov 16Investor's Business DailyAMGN
      Novo Nordisk vs. Amgen: 1 Has the Blockbuster Weight-Loss Drugs, the Other Has a Promising Rival
      Nov 16BarchartAMGNNVO
      Is Amgen Stock Still Telling Investors The Same Thing?
      Nov 16Yahoo FinanceAMGN
      Here’s How Much You Would Have Made Owning Amgen Stock In The Last 15 Years
      Nov 13BenzingaAMGN
      Is Amgen Stock Priced Right Against Its Peers?
      Nov 12Yahoo FinanceAMGN
      Argus raises Amgen stock price target on pipeline strength
      Nov 12Investing.comAMGN
      Amgen’s acquired Sjögren’s drug a Phase III hit
      Nov 12Yahoo FinanceAMGN
      45 ETFs Add to Amgen (AMGN) Holdings on Tuesday
      Nov 12Yahoo FinanceAMGN
      Amgen (AMGN) Stock Looks Cheap Based On Future Cash Flow
      Nov 11Yahoo FinanceAMGN
      Amgen Reports Phase 3 Dazodalibep Trial Meets Primary Endpoint in Sjögren’s Disease
      Nov 11Yahoo FinanceAMGN
      Amgen Experimental Drug Shows Symptom Reductions in Chronic Autoimmune Disease That Impacts Tears
      Nov 11BenzingaAMGN
      Amgen's Sjogren's drug cuts disease activity in trial
      Nov 11ReutersAMGN
      Amgen reports positive phase 3 trial results for Sjögren’s treatment
      Nov 11Investing.comAMGN
      How Amgen, In A Buy Zone, Is Taking On Novartis With A First-Ever

      Amgen unveiled test results Wednesday that suggest it could have one of the first immune-modulating treatments for Sjogren's.

      Nov 11Investor's Business DailyAMGNNVS
      iShares Biotechnology ETF (IBB) Adds Gilead and Amgen on Nov. 9
      Nov 11Yahoo FinanceAMGNGILDIBB
      Amgen vs. Regeneron: Higher Dividends Now or Bigger Growth Later?
      Nov 10Yahoo FinanceAMGNREGN
      Amgen Inc. stock rises Monday, still underperforms market
      Nov 9MarketWatchAMGN
      Here is What to Know Beyond Why Amgen Inc. (AMGN) is a Trending Stock

      Amgen (AMGN) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

      Nov 9Yahoo FinanceAMGN
      Amgen’s Repatha shows cost-effectiveness in cardiovascular study
      Nov 9Yahoo FinanceAMGN
      Amgen’s new drug could mean fewer shots for obesity patients
      Nov 8TheStreetAMGN
      Amgen’s Dividend Has Grown 800% Since 2011. Here’s What It Pays Today
      Nov 8Yahoo FinanceAMGN
      Freedom Broker downgrades Amgen stock rating on valuation despite raising price target
      Nov 6Investing.comAMGN
      57 ETFs Add to Amgen (AMGN) Holdings on Wednesday

      ETFs bought a net $79.8 million of Amgen stock in Wednesday's session.

      Nov 6Yahoo FinanceAMGN
      Amgen Earnings Call Highlights Growth, Pipeline Momentum

      Detailed price information for Amgen Inc (AMGN-Q) from The Globe and Mail including charting and trades.

      Nov 6The Globe and MailAMGN
      Amgen Inc. stock underperforms Thursday when compared to competitors
      Nov 5MarketWatchAMGN
      What Are Amgen Investors Betting On?
      Nov 5Yahoo FinanceAMGN
      Amgen Inc. stock underperforms Wednesday when compared to competitors despite daily gains
      Nov 4MarketWatchAMGN
      Amgen Analyst Likes Diversified Business, Remains Patient Until MariTide Obesity Data
      Nov 4BenzingaAMGN
      Amgen earnings analysis: questions answered and next catalysts
      Nov 4Investing.comAMGN
      Amgen Stocks Rise 5.91% as Higher Guidance Narrows the Remaining Earnings Test
      Nov 4Yahoo FinanceAMGN
      Amgen (AMGN) Q3 2026 Earnings Call Transcript | The Motley Fool

      Six growth drivers now account for 70% of product sales as guidance was raised.

      Nov 4The Motley FoolAMGN
      RBC Capital raises Amgen stock price target on strong earnings beat
      Nov 4Investing.comAMGN
      UBS raises Amgen stock price target to $530 on diversification
      Nov 4Investing.comAMGN
      Bernstein raises Amgen stock price target on growth and margin strength
      Nov 4Investing.comAMGN
      Cantor Fitzgerald raises Amgen stock price target to $465 on solid quarter
      Nov 4Investing.comAMGN
      Amgen stock price target raised to $531 by TD Cowen on growth
      Nov 4Investing.comAMGN
      AMGN Stock Down Despite Q3 Earnings & Sales Beat, Raised Guidance

      Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.

      Nov 4The Globe and MailAMGN
      $1000 Invested In Amgen 15 Years Ago Would Be Worth This Much Today
      Nov 4BenzingaAMGN
      Truist raises Amgen stock price target on earnings beat
      Nov 4Investing.comAMGN
      Amgen Inc. Q3 2026 Earnings Call Summary
      Nov 4Yahoo FinanceAMGN
      How Investors May Respond To Amgen (AMGN) Earnings Beat
      Nov 4Yahoo FinanceAMGN
      Canaccord raises Amgen stock price target on strong quarter, pipeline wins
      Nov 4Investing.comAMGN
      Amgen (NASDAQ:AMGN) exceeds Q3 2026 expectations, full-year outlook slightly exceeds expectations

      Detailed price information for Amgen Inc (AMGN-Q) from The Globe and Mail including charting and trades.

      Nov 4The Globe and MailAMGN
      Amgen beats third quarter forecasts on top and bottom lines
      Nov 4Investing.comAMGN
      Wells Fargo raises Amgen stock price target on strong momentum
      Nov 4Investing.comAMGN
      AMGN Q3 2026 deep dive: robust product sales and pipeline advances drive guidance increase

      Detailed price information for Amgen Inc (AMGN-Q) from The Globe and Mail including charting and trades.

      Nov 4The Globe and MailAMGN
      Amgen Inc (AMGN) (Q3 2026) Earnings Call Highlights: Revenue Up 8% to $10. ...

      Amgen Inc (AMGN) lifted its 2026 revenue and EPS outlook as six key growth drivers surged 27%, offsetting a TEPEZZA decline and pending MariTide data.

      Nov 4Yahoo FinanceAMGN
      Amgen posts higher-than-expected third quarter results, but shares dip By Reuters
      Nov 4Investing.comAMGN
      What Amgen (AMGN) Said on Its Q3 Earnings Call
      Nov 4Yahoo FinanceAMGN

      This is the newest page. Registered accounts read further back.